glp-1 colorectal cancer mortality study november 2025 If you are taking a for diabetes or weight loss, a new found it may also be lowering your risk of colon cancer. Researchers analyzed health records for 281,000 people GLP-1 agonists reduce colon cancer
Description
Doal GLP-1 ise vcudun kendi rettii hormonal yanttr
M.et al (2022)
If retatrutide gains regulatory approval, wider availability could ensue across the world
Tichansky DS, Boughter JD, Madan AK
Sukumar J., Raghavendra A., Pasyar S., et al., Retrospective Study of GLP1 Receptor Agonists in Breast Cancer Survivors: Weight Loss and Patient Outcomes, Presented at the San Antonio Breast Cancer Symposium (SABCS), December 1013, 2024
Similarly, the appetite-suppressing effects of liraglutide have been traced to its action within the arcuate nucleus (ARC) of the hypothalamus, a region also characterized by a relatively permeable BBB (Secher et al., 2014)
